Skip to main content

Two medicines, side by side

Budesonide vs prednisolone

Budesonide and prednisolone are both labeled for asthma, allergies and crohn's disease and ulcerative colitis. Drugs@FDA records approvals of budesonide since 1994 and of prednisolone since 1955. Pharmacies paid $0.498 per budesonide DR 3 mg capsule and $4.72 per mL (Prednisolone ac 1% eye drop) (NADAC, October 7, 2026); the strengths differ, so the two prices are not like for like. Budesonide's other strengths are brand-only: $3.29 per mL (Eohilia 2 mg/10 mL packet). Prednisolone's other strengths are brand-only: $30.66 per mL (Pred mild 0.12% eye drops).

Check it at the source: the budesonide FDA label on DailyMed (effective October 11, 2019); the prednisolone FDA label on DailyMed (effective June 25, 2026).

Highlights of the budesonide record

Budesonide (Pulmicort) · label of October 11, 2019

Used for

From the label: indications

PULMICORT RESPULES ® is an inhaled corticosteroid indicated for: • Maintenance treatment of asthma and as prophylactic therapy in children 12 months to 8 years of age ( 1 ) Limitations of Use: Not indicated for the relief of acute bronchospasm ( 1 ) 1.1 Maintenance Treatment of Asthma PULMICORT RESPULES is indicated for the maintenance treatment of asthma and as prophylactic therapy in children 12 months to 8 years of age. […]

On the market

Earliest approval on file
February 14, 1994
Generic labelers
30 labelers
Pharmacy cost
$0.498 per capsule

Supply and safety

Shortage
No current entry
Recalls
9

Highlights of the prednisolone record

Prednisolone (Pred) · label of June 25, 2026

Used for

From the label: indications

Prednisolone Sodium Phosphate Oral Solution is indicated in the following conditions: 1. Allergic States Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in adult and pediatric populations with: seasonal or perennial allergic rhinitis; asthma; contact dermatitis; atopic dermatitis; serum sickness; drug hypersensitivity reactions. 2. […]

On the market

Earliest approval on file
May 22, 1955
Generic labelers
25 labelers
Pharmacy cost
$4.72 per mL

Supply and safety

Shortage
No current entry
Recalls
9

Source: FDA drug labels via openFDA (Budesonide label of October 11, 2019, Prednisolone label of June 25, 2026); NDC Directory, Drugs@FDA, NADAC, FDA shortages and recalls (October 8, 2026)

How do budesonide and prednisolone differ on the record?

Both are in FDA's class corticosteroids.

Generics: budesonide since 2008; prednisolone since 1971 (Drugs@FDA).

BudesonidePrednisolone
Labeled forAsthma, Allergies, Crohn's disease and ulcerative colitisAnemia, Leukemia, lymphoma and myeloma, Multiple sclerosis, Osteoarthritis, Asthma, Allergies, Herpes and shingles, Crohn's disease and ulcerative colitis, Eczema (atopic dermatitis), Organ transplant rejection
Pharmacologic classCorticosteroidCorticosteroid
How it works (label)Budesonide is an anti-inflammatory corticosteroid that exhibits potent glucocorticoid activity and weak mineralocorticoid activity.n/a
Half-life (label)n/aPrednisolone is 70-90% protein-bound in the plasma and it is eliminated from the plasma with a half-life of 2 to 4 hours.
Earliest approval on file (Drugs@FDA)February 14, 1994May 22, 1955
First generic approvedNovember 18, 2008November 24, 1971
Generic labelers (NDC)30 labelers25 labelers
Pharmacy cost (NADAC, each one's most listed form; strengths differ)$0.498 per capsule (Budesonide DR 3 mg capsule)$4.72 per mL (Prednisolone ac 1% eye drop)
12-month price change-3%+4%
Boxed warningNoNo
Shortage nowNo current entryNo current entry
Recalls recorded99
FAERS reports (a report is not proof of cause; counts follow how widely a medicine is used)58,575191,407
DEA schedulenonenone

Source: Drugs@FDA, FDA NDC Directory, CMS NADAC of October 7, 2026, FDA shortages and recalls, FAERS via openFDA (FDA files October 8, 2026)

What next?

Alternatives to budesonide
every medicine labeled for the same conditions